Connect Biopharma Holdings Ltd Cash Flow Quality Index

Latest as of June 2024: -1.35x

Connect Biopharma Holdings Ltd cash flow quality index. Connect Biopharma Holdings Ltd (CNTB) has a Cash Flow Quality Index of -1.35x as of June 2024. Operating cash flow of $-8.29 Million is below net income of $6.15 Million, suggesting accrual-heavy earnings not yet converted to cash. See CNTB financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-1.35x
Operating CF / Net Income

Operating Cash Flow

$-8.29 Million
USD

Net Income

$6.15 Million
USD

Data as of

Jun 2024
Most recent filing

Connect Biopharma Holdings Ltd Cash Flow Quality Index by Year (None–None)

Connect Biopharma Holdings Ltd cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Connect Biopharma Holdings Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Connect Biopharma Holdings Ltd.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.